AAPGV (Ascentage Pharma Group Ltd) Net earnings per share (EPS TTM)

Public company logo of Ascentage Pharma Group Ltd (AAPGV)

The EPS YoY TTM growth trajectory on the GURU.Markets chart demonstrates profit dynamics, where the value of -12.30 corresponds to the current metric. Ascentage Pharma Group (AAPGV) capitalization relies on partner payments and drug sales in the US and China. The biotech company develops innovative cancer treatment methods, targeting oncology centers. Production is supported by the modernization of facilities for the manufacture of small-molecule drugs.

Ascentage Pharma Group Ltd - AAPGV Net earnings per share (EPS TTM) (period 11/23/2025 - 11/17/2026)

AAPGV (ascentage.com): analytical breakdowns and indicator data

- market value and analyst target forecast:
- business market valuation indicators:
Fundamental company valuation:Ascentage Pharma Group
Mass-produced product of Ascentage Pharma Group

This indicator captures the dynamics of the rolling annual earnings per share. By analyzing the 12-month EPS YoY percentage change, an investor tracks the growth rate of net income. The calculation is based on a comparison of the current TTM value with the same period last year. For Ascentage Pharma Group (AAPGV), such fluctuations reflect financial stability against the backdrop of oncology drug development costs. High volatility in this metric confirms the capital's dependence on clinical trial results.

Competitor analysis for Ascentage Pharma Group

Earnings per share for the trailing year ONC (BeiGene)|Halozyme Inc. (HALO) - Earnings per share for the last twelve months|RevMed - Earnings per share for the trailing year|AAPG (Ascentage Pharma Group International) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months CG Oncology, Inc. CGON|Net earnings per share for the last 12 months URGN (urogen.com)|Earnings per share for the last twelve months BCAX (Bicara Therapeutics)|Net earnings per share (EPS TTM) PSNL (personalis.com)|Earnings per share for the trailing year ERAS|DCTH - Earnings per share for the last twelve months|Y-mAbs Therapeutics (YMAB) - Net earnings per share for the last 12 months|AURA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CADL|Earnings per share for the last twelve months Accuray Inc.|SELLAS Life Sciences Group (SLS) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ACTU (Actuate Therapeutics, Inc)|Net earnings per share for the last four quarters Citius Oncology|TuHURA Biosciences, Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Protara TARA|fatetherapeutics.com - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aadi Bioscience|TCRX: Net earnings per share (EPS TTM)|CSBR - Net earnings per share for the last four quarters|XBIT (XBiotech) - Net earnings per share (EPS TTM)|CVM: Earnings per share for the trailing year|Net earnings per share (EPS TTM) OSTX|RADX (Radiopharm Theranostics Limited) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ARTV (Artiva Biotherapeutics, Inc.)|Earnings per share for the trailing year ANL|VERU: Net earnings per share for the last 12 months|TPST - Net earnings per share (EPS TTM)|XLO (xiliotx.com) - Net earnings per share for the last 12 months|Renovaro Biosciences - Earnings per share for the trailing year|Net earnings per share for the last 12 months MURA|Earnings per share for the last twelve months KAPA|Net earnings per share for the last 12 months OKUR (OnKure Therapeutics Inc)|Net earnings per share (EPS TTM) CytoMed (GDTC)|Earnings per share for the last twelve months curis.com CRIS|APLM (Apollomics, Inc.) - Earnings per one share for the last 12 months|Tharimmune Corporation - Net earnings per share (EPS TTM)|ADVB (advanbiomed.com) - Earnings per share for the last 12 months|Genprex, Inc (GNPX) - Earnings per share for the last twelve months|CLDI: Earnings per share for the last four quarters|SBFM (Sunshine Biopharma, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months XBIO (Xenetic Biosciences)|Net earnings per share (EPS TTM) SLRX|Purple Biotech - Earnings per share for the last 12 months|American Oncology Network - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGNE|CKPT - Earnings per share for the last twelve months|Elevation Oncology (ELEV) - Net earnings per share for the last 12 months|ICAD: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Ikena Oncology Inc.|NTBL (Notable Labs Ltd) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Viracta Therapeutics (VIRX)|Earnings per share for the last twelve months MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Earnings per share for the trailing year